DHC Q1 2026 Earnings Call Transcript

Diversified Healthcare Trust posted a strong Q1 with normalized FFO of $33.1 million ($0.14/share) and adjusted EBITDAre of $74 million, both ahead of consensus, while consolidated NOI rose 4.7% to $75.9 million. Same-property SHOP NOI jumped 13.5% year over year to $44.3 million on 110 bps occupancy improvement and 5.9% rate growth, and MOLS NOI increased 3.7% to $25.4 million. Management reaffirmed 2026 guidance, including $290 million-$305 million of adjusted EBITDAre and $0.52-$0.58/share normalized FFO, while leverage improved to 7.8x net debt/EBITDAre, liquidity totaled $272 million, and Moody’s upgraded the company to B3 with a positive outlook.

Analysis

The key signal is not the headline operating beat; it is that DHC is converting transition pain into a multi-quarter margin expansion story before the full occupancy benefits even show up. The combination of operator churn, food/labor contract resets, and reduced contract labor suggests the portfolio is still in the early innings of a cost-reset cycle, which means near-term upside is more likely to come from margins than from unit growth. That matters because senior housing names usually get re-rated on occupancy inflection, but here the more durable catalyst is that each incremental dollar of revenue should flow through at a higher rate once the expense base is normalized.

The balance sheet improvement is also more powerful than it looks. With no maturities until 2028 and a large unencumbered asset base, management now has optionality to self-fund repositioning rather than chase external capital, which lowers the probability of value-destructive dilution or forced asset sales. The Moody’s upgrade is important second-order support for refinancing optionality, but the bigger effect is that it can compress the equity risk premium in a name that has historically been treated like a distressed REIT despite now behaving more like a self-help compounder.

The market may be underestimating the timing asymmetry in the renovation pipeline. The 2023-24 refresh wave should start contributing more visibly over the next 12 months, while the 2025 projects mostly hit later in 2026 and into 2027, creating a stacked benefit profile that can sustain earnings momentum beyond one quarter. The contrarian risk is that guidance still assumes occupancy improvement that has not yet shown up, so if seasonal softness or operator disruption delays that ramp, the stock can re-rate down quickly from a high expectations base.

Key Decisions for Investors

• Long DHCNL common equity over a 3-6 month horizon: the setup favors continued de-risking and multiple expansion if Q2/Q3 confirms margin-led earnings upside; stop if SHOP occupancy fails to improve by the back half of the year.
• Sell puts on DHC common into any post-earnings pullback, targeting strikes 10-15% below spot for 2-3 month maturities; premium should reflect improving credit and rising self-help visibility.
• Pair trade: long DHC / short a slower-turnaround senior housing REIT with weaker balance sheet and fewer unencumbered assets; the spread should widen if DHC’s renovation flow-through shows up before peers’ occupancy recoveries.
• For more asymmetric exposure, buy DHC calls 6-9 months out rather than stock if implied volatility is reasonable; the key catalyst window is the next two quarters when 2023-25 capital spend begins to flow through NOI.